首页> 外文期刊>American Journal of Pathology >Primary Cutaneous CD8-Positive Epidermotropic Cytotoxic T Cell Lymphomas : A Distinct Clinicopathological Entity with an AggressiveClinical Behavior
【24h】

Primary Cutaneous CD8-Positive Epidermotropic Cytotoxic T Cell Lymphomas : A Distinct Clinicopathological Entity with an AggressiveClinical Behavior

机译:原发性皮肤CD8阳性表皮细胞毒性T细胞淋巴瘤:具有侵略性临床行为的不同临床病理实体。

获取原文
获取原文并翻译 | 示例
       

摘要

Cutaneous T cell lymphomas (CTCL) generally have the phenotype of CD3+, CD4+, CD45RO+ memory T cells. CTCL expressing a CD8+ T cell phenotype are extremely rare and ill-defined. To elucidate whether these CD8+ CTCL represent a distinct disease entity, the clinical, histological, and immunophenotypical features of 17 CD8+ CTCL were reviewed. None of the 17 cases expressed markers characteristic of natural killer cells or / T cells. Nine of 17 cases showed the characteristic clinical and histological features as well as clinical behavior of well defined types of CTCL, such as mycosis fungoides (2 cases), pagetoid reticulosis (2 cases), lymphomatoid papulosis (2 cases), and CD30+ large T cell lymphoma (2 cases), all of which usually express a CD4+ T cell phenotype, and 1 case of subcutaneous panniculitis-like T cell lymphoma. The other 8 cases formed a homogeneous group showing a distinctive set of clinicopathological and immunophenotypical features, not consistent with that of other well defined types of CTCL. Clinical characteristics included presentation with generalized patches, plaques, papulonodules, and tumors mimicking disseminated pagetoid reticulosis; metastatic spread to unusual sites, such as the lung, testis, central nervous system, and oral cavity, but not to the lymph nodes; and an aggressive course (median survival, 32 months). Histologically, these lymphomas were characterized by band-like infiltrates consisting of pleomorphic T cells or immunoblasts, showing a diffuse infiltration of an acanthotic epidermis with variable degrees of spongiosis, intraepidermal blistering, and necrosis. The neoplastic cells showed a high Ki-67 proliferation index and expression of CD3, CD8, CD7, CD45RA, ßF1, and TIA-1 markers, whereas CD2 and CD5 were frequently lost. Expression of TIA-1 pointed out that these lymphomas are derived from a cytotoxic T cell subset. The results of this and other studies reviewed herein suggest that these strongly epidermotropic primary cutaneous CD8+ cytotoxic T cell lymphomas represent a distinct type of CTCL with an aggressive clinical behavior.
机译:皮肤T细胞淋巴瘤(CTCL)通常具有CD3 +,CD4 +,CD45RO +记忆T细胞的表型 。表达CD8 + T细胞表型的CTCL非常罕见且定义不清。为阐明 这些CD8 + CTCL是否代表不同的疾病实体,我们对17种CD8 + CTCL 的临床, 组织学和免疫表型特征进行了综述。 17例病例均未表达天然杀伤细胞或/ T细胞特征性标记物 。 17例中的9例表现出 特征性临床和组织学特征 以及明确定义的CTCL类型的临床行为,如 真菌病真菌(2例),页面状网状网状病变(2例), 淋巴瘤样丘疹(2例)和CD30 +大T细胞淋巴瘤 (2例),通常都表达CD4 + T细胞表型, 和1例皮下脂膜炎样T细胞淋巴瘤。 其他8例形成一个均质组,表现出独特的临床病理学特征。和免疫表型特征, 与其他定义明确的CTCL类型不一致。 临床特征包括全身性 斑块,斑块,丘疹和模仿扩散的 pagetoid网状细胞的肿瘤;转移扩散到异常部位,例如肺,睾丸,中枢神经系统和口腔, ,但不扩散到淋巴结;和激进的课程(中位 生存期,为32个月)。组织学上,这些淋巴瘤的特征是由多形性T细胞或 成免疫细胞组成的带状浸润,表现出棘突性表皮的弥漫性浸润。海绵状程度,表皮内 起泡和坏死。肿瘤细胞显示高 Ki-67增殖指数,并表达CD3,CD8,CD7,CD45RA,ßF1, 和TIA-1标记,而CD2和CD5则很常见TIA-1的表达指出,这些淋巴瘤 来自细胞毒性T细胞亚群。本文回顾的该研究结果和其他研究结果表明,这些强烈的表皮原发性皮肤CD8 +细胞毒性T细胞淋巴瘤代表CTCL的独特类型,具有侵略性的临床行为。

著录项

  • 来源
    《American Journal of Pathology》 |1999年第2期|483-492|共10页
  • 作者单位

    From the Institute of Dermatologic Science and IRCCS Ospedale Maggiore,Milan, Italy;

    the Department of Dermatology,Ospedale Busto Arsizio, Italy;

    and the Departments of Dermatology and Pathology,Free University Hospital, Amsterdam, The Netherlands;

    and the Departments of Dermatology and Pathology,Free University Hospital, Amsterdam, The Netherlands;

    From the Institute of Dermatologic Science and IRCCS Ospedale Maggiore,Milan, Italy;

    and the Departments of Dermatology and Pathology,Free University Hospital, Amsterdam, The Netherlands;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 14:17:19

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号